Literature DB >> 19057971

Simultaneous isolation of vascular endothelial cells and mesenchymal stem cells from the human umbilical cord.

Sachin S Kadam1, Shubha Tiwari, Ramesh R Bhonde.   

Abstract

The umbilical cord represents the link between mother and fetus during pregnancy. This cord is usually discarded as a biological waste after the child's birth; however, its importance as a "store house" of stem cells has been explored recently. We developed a method of simultaneous isolation of endothelial cells (ECs) from the vein and mesenchymal stem cells from umbilical cord Wharton's jelly of the same cord. The isolation protocol has been simplified, modified, and improvised with respect to choice of enzyme and enzyme mixture, digestion time, cell yield, cell growth, and culture medium. Isolated human umbilical vascular ECs (hUVECs) were positive for von-Willibrand factor, a classical endothelial marker, and could form capillary-like structures when seeded on Matrigel, thus proving their functionality. The isolated human umbilical cord mesenchymal stem cells (hUCMSCs) were found positive for CD44, CD90, CD 73, and CD117 and were found negative for CD33, CD34, CD45, and CD105 surface markers; they were also positive for cytoskeleton markers of smooth muscle actin and vimentin. The hUCMSCs showed multilineage differentiation potential and differentiated into adipogenic, chondrogenic, osteogenic, and neuronal lineages under influence of lineage specific differentiation medium. Thus, isolating endothelial cells as well as mesenchymal cells from the same umbilical cord could lead to complete utilization of the available tissue for the tissue engineering and cell therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19057971     DOI: 10.1007/s11626-008-9155-4

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  20 in total

1.  Mesenchymal progenitor cells in human umbilical cord blood.

Authors:  A Erices; P Conget; J J Minguell
Journal:  Br J Haematol       Date:  2000-04       Impact factor: 6.998

2.  Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood.

Authors:  K Mareschi; E Biasin; W Piacibello; M Aglietta; E Madon; F Fagioli
Journal:  Haematologica       Date:  2001-10       Impact factor: 9.941

3.  Isolation of multipotent mesenchymal stem cells from umbilical cord blood.

Authors:  Oscar K Lee; Tom K Kuo; Wei-Ming Chen; Kuan-Der Lee; Shie-Liang Hsieh; Tain-Hsiung Chen
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

4.  Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord.

Authors:  Yuri A Romanov; Veronika A Svintsitskaya; Vladimir N Smirnov
Journal:  Stem Cells       Date:  2003       Impact factor: 6.277

5.  CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients.

Authors:  Jean-Philippe Dales; Stephane Garcia; Pascal Bonnier; Florence Duffaud; Lucile Andrac-Meyer; Olivier Ramuz; Marie-Noëlle Lavaut; Claude Allasia; Colette Charpin
Journal:  Am J Clin Pathol       Date:  2003-03       Impact factor: 2.493

6.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

7.  First report of autologous cord blood transplantation in the treatment of a child with leukemia.

Authors:  Ammar Hayani; Eberhard Lampeter; David Viswanatha; David Morgan; Sharad N Salvi
Journal:  Pediatrics       Date:  2007-01       Impact factor: 7.124

8.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

Review 9.  Wharton's jelly-derived cells are a primitive stromal cell population.

Authors:  Deryl L Troyer; Mark L Weiss
Journal:  Stem Cells       Date:  2007-12-06       Impact factor: 6.277

10.  Multipotent stem cells from umbilical cord: cord is richer than blood!

Authors:  Mariane Secco; Eder Zucconi; Natassia M Vieira; Luciana L Q Fogaça; Antonia Cerqueira; Maria Denise F Carvalho; Tatiana Jazedje; Oswaldo K Okamoto; Alysson R Muotri; Mayana Zatz
Journal:  Stem Cells       Date:  2007-10-11       Impact factor: 6.277

View more
  15 in total

1.  Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Abdul Manaf Ali; Abdul Rahman Omar; Maryam Mohit; Ehsan Janzamin; Fazel Sahraneshin Samani; Zahra Torshizi; Seyed Noureddin Nematollahi-Mahani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-01-25       Impact factor: 2.416

Review 2.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 3.  Implantation of human umbilical cord mesenchymal stem cells for ischemic stroke: perspectives and challenges.

Authors:  Yingchen Li; Guoheng Hu; Qilai Cheng
Journal:  Front Med       Date:  2014-12-09       Impact factor: 4.592

4.  Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially.

Authors:  S Jyothi Prasanna; Divya Gopalakrishnan; Shilpa Rani Shankar; Anoop Babu Vasandan
Journal:  PLoS One       Date:  2010-02-02       Impact factor: 3.240

5.  Toxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint.

Authors:  Junchao Duan; Yongbo Yu; Yang Li; Yang Yu; Yanbo Li; Xianqing Zhou; Peili Huang; Zhiwei Sun
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

6.  Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.

Authors:  Tereza C Cardoso; Heitor F Ferrari; Andrea F Garcia; Juliana B Novais; Camila Silva-Frade; Marina C Ferrarezi; Alexandre L Andrade; Roberto Gameiro
Journal:  BMC Biotechnol       Date:  2012-05-04       Impact factor: 2.563

7.  Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications.

Authors:  Andrea Lindenmair; Tim Hatlapatka; Gregor Kollwig; Simone Hennerbichler; Christian Gabriel; Susanne Wolbank; Heinz Redl; Cornelia Kasper
Journal:  Cells       Date:  2012-11-12       Impact factor: 6.600

8.  Effect of Fagonia arabica on thrombin induced release of t-PA and complex of PAI-1 tPA in cultured HUVE cells.

Authors:  Prutha D Aloni; Amit R Nayak; Sweta R Chaurasia; Jayant Y Deopujari; Chhaya Chourasia; Hemant J Purohit; Girdhar M Taori; Hatim F Daginawala; Rajpal S Kashyap
Journal:  J Tradit Complement Med       Date:  2015-04-03

9.  Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.

Authors:  Maria Cristina Corotchi; Mirel Adrian Popa; Anca Remes; Livia Elena Sima; Ilinca Gussi; Marilena Lupu Plesu
Journal:  Stem Cell Res Ther       Date:  2013-07-11       Impact factor: 6.832

10.  Synergistic effect of bioactive lipid and condition medium on cardiac differentiation of human mesenchymal stem cells from different tissues.

Authors:  Lili Jiang; Yanwen Wang; Fang Pan; Xiubo Zhao; Henggui Zhang; Ming Lei; Tianqing Liu; Jian R Lu
Journal:  Cell Biochem Funct       Date:  2016-03-16       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.